Unlocking Opportunities in the Platelet Aggregation Devices Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Platelet Aggregation Devices Industry Market Size Be by 2025?
In recent years, there has been a monumental expansion in the market size of platelet aggregation devices. The market's worth is projected to surge from $0.83 billion in 2024 to $1.05 billion in 2025, amounting to a compound annual growth rate (CAGR) of 25.8%. The growth observed in the past can be ascribed to the increased occurrence of cardiovascular ailments, escalating instances of bleeding disorders, heightened awareness of health diagnostics, rise in the number of surgical procedures, and enhanced diagnostic precision.

What's the Long-Term Growth Forecast for the Platelet Aggregation Devices Market Size Through 2029?
In the coming years, the market size of platelet aggregation devices is projected to undergo exceptional growth, reaching a value of $2.59 billion in 2029, with a compound annual growth rate (CAGR) of 25.4%. This surge in growth during the predicted period can be ascribed to numerous factors such as the expanding elderly population, increasing demand for onsite testing, growth of individualized medicine, regulatory assistance and authorization, and a rise in the prevalence of persistent diseases. Noteworthy tech advancements in the forecast period are the application of artificial intelligence in diagnostic processes, the creation of mobile platelet aggregation devices, heightened synergy among biotech companies and health service providers, the escalating relevance of data analysis in the medical field, and the transition towards home-based diagnostic services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Are the Key Growth Drivers Fueling the Platelet Aggregation Devices Market Expansion?
The escalating occurrence of focus diseases is projected to fuel the expansion of the platelet aggregation devices market. Focus diseases are specific health conditions that significantly affect public health like cancer, cardiovascular conditions, and diabetes, and are a priority in terms of prevention, diagnosis, and treatment. Platelet aggregation devices play a significant role in reducing the prevalence of such diseases by facilitating early identification and efficient handling of thrombotic threats, thereby avoiding complications such as heart attacks and strokes in susceptible groups. As an instance, in February 2024, the International Agency for Research on Cancer (IARC), a France-based specialized cancer branch of the World Health Organization (WHO), reported that there were around 20 million fresh cases of cancer and about 9.7 million deaths in 2022, and forecasts suggest a 77% rise to over 35 million new cases by 2050; lung cancer accounted for the majority of these cases globally with 2.5 million new instances (12.4%), trailed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Hence, the increasing occurrence of focus diseases is propelling the growth of the platelet aggregation devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Are the Key Trends Driving Platelet Aggregation Devices Market Growth?
Leading firms in the platelet aggregation devices industry are focusing more on creating cutting-edge solutions through the launch of revolutionary products like the first platelet pooling set to aid in the stabilization of the platelet supply in the U.S. and to meet escalating needs. The platelet pooling set is a highly specialized medical instrument used in plateletpheresis procedures to gather and concentrate platelets from various donors into a singular unit for transfusion therapy purposes. For example, in February 2023, TERUMO BCT INC., a brand from the United States that provides blood components and cellular technology, announced the Food and Drug Administration (FDA)'s approval of the IMUGARD WB Platelet Pooling Set. This contributes to an increased shelf life for platelets, seven-day storage clearance from the FDA, and allows recovery of platelets from complete blood donations, boosting adaptability and accessibility in the platelet aggregation devices market. This introduction signifies a crucial technological progression by meeting the need for enhanced platelet availability, better supply chain management, and aiding the challenged U.S. platelet supply to meet the growing demand in crucial health procedures like chemotherapy and organ transplantation.

How Is the Platelet Aggregation Devices Market Segmented?
The platelet aggregation devices market covered in this report is segmented -

1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Companies Are Leading the Charge in Platelet Aggregation Devices Market Innovation?
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Which Regions Are Leading the Global Platelet Aggregation Devices Market in Revenue?
North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.